4//SEC Filing
Allen Andrew R 4
Accession 0001104659-24-076887
CIK 0001621227other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:00 PM ET
Size
5.7 KB
Accession
0001104659-24-076887
Insider Transaction Report
Form 4
Allen Andrew R
Director
Transactions
- Award
Option to purchase Ordinary Shares
2024-07-01+660,000→ 660,000 totalExercise: $0.16From: 2025-07-01Exp: 2034-07-01→ Ordinary Shares (660,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.13 based on an exchange rate of $U.S. 1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001374539
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:00 PM ET
- Size
- 5.7 KB